REPORTER LABELED ANNULAR CLOT SYSTEM FOR DIAGNOSIS AND RESEARCH

ASSESSMENT OF THE RISK OF COMPLICATION IN A PATIENT SUSPECTED OF HAVING AN INFECTION, HAVING A SOFA SCORE LOWER THAN TWO

APPARATUS AND METHOD FOR EARLY IDENTIFICATION OF tPA RESISTANCE FOR CLOT DISSOLUTION IN PATIENTS

METHOD FOR PREDICTING TREATMENT RESPONSE AND TEST FOR SAFE USE OF MESENCHYMAL STEM CELLS ON INFLAMMATORY DISEASES

METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR

CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY

Nucleic acid ligand complexes

PLASMINOGEN ACTIVATOR INHIBITOR AMELIORATION OF NEWBORN HYPOXIC ISCHEMIC BRAIN INJURY

METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR

DIAGNOSTIC BIOMARKERS FOR VASCULAR ANEURYSM

Cross-β structure comprising amyloid-binding proteins and methods for detection of the cross-β structure, for modulating cross-β structures fiber formation and modulating cross-β structure-mediated toxicity

Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor

Cross-beta structures on microbial organisms

Tenascin-C nucleic acid ligands

Systematic evolution of ligands by exponential enrichment: Chemi-SELEX

Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity

Nucleic acid ligand complexes

Truncation SELEX method

High affinity RNA ligands of basic fibroblast growth factor

Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein